🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: 1\. Monitor adverse events (Adverse Event Following Imm...
Status
Unknown
Location
AOU Policlinico Umberto I
Start Date
2021-02-11
Trial ID
NCT04844632
Treatments Being Tested
Vaccination coverage against COVID-19 differs widely between countries: in ...
Status
Unknown
Location
University of Turin
Start Date
2022-06-20
Trial ID
NCT05471635
Treatments Being Tested
Aim: To investigate if a subcutaneous (s.c.) booster dose of 90 µg of the n...
Status
Unknown
Location
University Medical Center Groningen
Start Date
2022-04-21
Trial ID
NCT05124483
Treatments Being Tested
The aim of the study is to evaluate the level of neutralizing antibody agai...
Status
Completed
Location
Hanyang University Seoul Hospital
Start Date
2021-04-20
Trial ID
NCT04871945
The objective of this research is to assess the amplitude and quality of th...
Status
Completed
Location
CHU lille
Start Date
2021-02-18
Trial ID
NCT04760704
Treatments Being Tested
This is a prospective biological study evaluating the persistence of COVID-...
Status
Active Not Recruiting
Location
Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico
Start Date
2024-05-07
Trial ID
NCT06070961
The aim of this study is to assess humoral immune response in kidney transp...
Status
Completed
Location
Institute for Clinical and Experimental Medicine
Start Date
2021-03-18
Trial ID
NCT04832841
Treatments Being Tested
Covid-19 has a very bad prognosis in solid organ transplant recipients with...
Status
Withdrawn
Location
Service de Néphrologie, Transplantation et Immunologie Clinique Hôpital Edouard Herriot - Hospices Civils de Lyon
Start Date
2022-02
Trial ID
NCT05234398
Treatments Being Tested
This is an adaptive Phase I-II trial of a vaccine consisting of autologous ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01
Trial ID
NCT04386252
Treatments Being Tested
This is a randomized, multi-site, adaptive, open-label clinical trial compa...
Status
Terminated
Location
UCLA Medical Center: Division of Rheumatology
Start Date
2021-08-13
Trial ID
NCT05000216
Treatments Being Tested